Q1 2016 Holdings
Filed 2016-05-16 | 94 holdings | $21.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atricure Inc(ATRC) | COM | 04963C209 | $8.2M | 488,446 | 38.0% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $6.7M | 116,581 | 30.8% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $1.1M | 140,265 | 5.0% |
| Ascendis Pharma(ASND) | ADR ADDED | 04351P101 | $988.0K | 53,241 | 4.6% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $738.0K | 176,232 | 3.4% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $716.0K | 88,100 | 3.3% |
| Caredx Inc(CDNA) | COM | 14167L103 | $675.0K | 136,047 | 3.1% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $592.0K | 65,700 | 2.7% |
| Beigene LTD(ONC) | SPONSORED ADR ADDED | 07725L102 | $586.0K | 20,000 | 2.7% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $476.0K | 115,230 | 2.2% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $423.0K | 149,642 | 2.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $392.0K | 55,600 | 1.8% |
| Nxstage Medical Inc | COM | 67072V103 | $5.9K | 396,554 | 0.0% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $5.2K | 787,373 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $3.9K | 1,876,492 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $3.6K | 171,881 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $3.5K | 106,018 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $3.4K | 140,313 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $3.0K | 566,498 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $3.0K | 76,300 | 0.0% |
| Novavax Inc | COM | 670002104 | $2.9K | 553,500 | 0.0% |
| Biotelemetry Inc(BEATEUR) | COM | 090672106 | $2.8K | 235,645 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $2.7K | 65,568 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K101 | $2.7K | 391,500 | 0.0% |
| Applied Genetic Technol Corp(2GT) | COM | 03820J100 | $2.3K | 167,192 | 0.0% |
| Insulet Corp | NOTE 2.000% 6/1 | 45784PAD3 | $2.3K | $2,407,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $2.2K | 179,769 | 0.0% |
| Masimo Corporation(MASI) | COM | 574795100 | $1.9K | 46,010 | 0.0% |
| Uniqure B.V.(QURE) | NV SHS | N90064101 | $1.9K | 158,907 | 0.0% |
| Achillion Pharmaceuticals(ACHNEUR) | COM | 00448Q201 | $1.8K | 236,500 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $1.7K | 267,046 | 0.0% |
| Protalix Biotherapeutics Inc | NOTE 4.500% 9/1 | 74365AAB7 | $1.6K | $2,500,000 | 0.0% |
| Ishares TR Nasdq Biotec(IBB) | ETF | 464287556 | $1.6K | 6,000 | 0.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $1.5K | 1,372,862 | 0.0% |
| Biospecifics Technologies(BSTC) | COM | 090931106 | $1.4K | 39,704 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.4K | 193,195 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $1.3K | 42,600 | 0.0% |
| Celyad | ADR | 151205200 | $1.3K | 30,000 | 0.0% |
| LDR Hldg Corp | COM | 50185U105 | $1.3K | 50,300 | 0.0% |
| Spectranetics Corp | COM | 84760C107 | $1.2K | 79,812 | 0.0% |
| Novadaq Technologies Inc | COM | 66987G102 | $1.1K | 101,841 | 0.0% |
| Derma Sciences Inc | COM PAR $.01 | 249827502 | $1.1K | 353,718 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $1.1K | 39,000 | 0.0% |
| Johnson and Johnson(JNJ) | COM | 478160104 | $1.0K | 9,400 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $1.0K | 54,200 | 0.0% |
| Lipocine Inc | COM NEW | 53630X104 | $972 | 95,731 | 0.0% |
| Medicinova Inc(MNOV) | COM NEW | 58468P206 | $918 | 125,000 | 0.0% |
| Discovery Laboratories Inc N COM PAR | COM PAR ADDED | 254668502 | $891 | 533,358 | 0.0% |
| Synergy Pharmaceuticals | COM | 871639308 | $813 | 294,563 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $774 | 118,671 | 0.0% |